neonatal liver biopsy

38
Neonatal Liver Biopsy Dr Claire Bowen Consultant Paediatric Pathologist

Upload: sana

Post on 11-Jan-2016

75 views

Category:

Documents


0 download

DESCRIPTION

Neonatal Liver Biopsy. Dr Claire Bowen Consultant Paediatric Pathologist. Topics Covered. Neonatal jaundice Indications for biopsy Handling of biopsy in the laboratory Histological assessment of the liver biopsy Patterns of liver disease with examples Biliary atresia A1AT - PowerPoint PPT Presentation

TRANSCRIPT

Neonatal Liver Biopsy

Dr Claire Bowen

Consultant Paediatric Pathologist

Topics Covered

• Neonatal jaundice• Indications for biopsy• Handling of biopsy in the laboratory• Histological assessment of the liver biopsy• Patterns of liver disease with examples

– Biliary atresia– A1AT– Cystic fibrosis– Neonatal hepatitis– Metabolic

Neonatal Jaundice• Common

– 60% term and 80% of preterm babies develop jaundice in first week of life

– 10% breast fed babies still jaundice at 1 month• Usually harmless

– High concentrations of conjugated hyperbilirubinaemia can cause permanent brain damage (kernicterus)

• Prolonged jaundice can be a sign of underling serious liver disease (conjugated bilirubinaemia >25 umol/L)

• Early recognition and prompt treatment essential– Phototherapy– Kasai portoenterostomy– Metabolic screening– Transplant

Indications

Biopsy indicated• Conjugated

hyperbilirubinaemia– Jaundice persisting

beyond 2 weeks (3 weeks in preterm babies)

– Dark urine– Pale stools

• Total parenteral nutrition in the context of intestinal failure

• Assessment of rejection post-transplant

• Tumour

Biopsy not indicated• Unconjugated

hyperbilirubinaemia – Physiological– Sepsis– Haemolysis

• Liver failure– Coagulopathic– Limited contribution to

aetiology– Usually see explanted

liver

Handling

• Procedure risk - general anaesthetic, bleeding

• Need maximum amount of information from biopsy

• Light microscopy

• Snap frozen tissue for metabolic cases

• Electron microscopy for storage disorders

• Dry tissue for copper

H&E• Number and size of tissue cores• Portal tracts

– Number– Presence/absence of bile ducts– Bile duct proliferation– Inflammation– Fibrosis

• Parenchyma– Giant cell transformation– Rosetting of hepatocytes– Haematopoiesis– Storage cells

• Central veins– Vascular flow abnormalites– Inflammation in rejection

Special stains

• Connective tissue stains to assess fibrosis– EVG – mature fibrosis/pericellular fibrosis

– Reticulin – cell plates, acute collapse

– Trichrome – tends to overestimate fibrosis

• Orcein - Copper associated protein and Hep B

• Perls to assess iron

• PAS/DPAS – glycogen, storage cells and Alpha-1-Antitrypsin globules

Van Gieson

Reticulin

Orcein

Perls

DPAS

Histological patterns

1) Biliary Features

• Fibrosis– Fibrous portal tract expansion– Bridging fibrosis– Lobular pattern of cirrhosis

• Ductular proliferation• Ductular bile plugging• Periportal copper-associated protein• Variable giant cell change• Haematopoiesis

Differential diagnosis

• Extrahepatic biliary atresia

• Alpha-1-antitrypsin (mimic)

• Total parenteral nutrition

• Cystic fibrosis – eosinophilic secretions in bile duct and fatty change

Biliary Atresia

• Rare - 1 in 17000 in UK• Presents in first few weeks• 50 cases a year with normal antenatal scans• 20% other anomalies (cardiac, polysplenia)• Lumen of biliary tree obliterated with

obstruction to bile flow• Progressive liver damage – cirrhosis• 5 categories of postulated aetiology –>

Inflammatory, Developmental, Vascular, Environmental and Viral

Alpha-1 Antitrypsin

• Defective A1AT protein• Defective production of A1AT leading to

decreased A1AT activity in the blood and lungs• Deposition of excessive abnormal A1AT protein in

liver cells. • Mimics – Can see biliary pattern or giant cell

pattern• PAS positive globules within hepatocytes – not

identified in first 3 months• Immuno for A1AT

Cystic Fibrosis

• Liver disease 5% in CF patients

• Fibrosis

• Cholestatsis

• Fatty change

• Biliary features

• Mucin in bile ducts characteristic but not always seen

2) Neonatal / giant cell hepatitis

• Largely normal portal tracts• Hepatocyte disarray and collapse• Florid giant cell change• Rosetting of hepatocytes• Cholestasis• Extramedullary haematopoiesis• May see storage cells• Not usually fibrotic

Differential diagnosis

• Idiopathic with spontaneous recovery• Infection• Metabolic• Storage• A1AT

3) Paucity of bile ducts

• Bile duct proper lacking

• Need at least 10 portal tracts (1 in 10 miss bile duct normally)

• Abberent periportal cytokeratin 7 expression– Normally stains biliary epithelium– Stains periportal hepatocytes where there is

duct loss

Differential diagnosis

• Syndromic– Alagilles syndrome

• Non-syndromic– CMV infection– A1AT– Cystic fibrosis– Chronic rejection

Alagille syndrome

• Characteristic facial features – triangular face• Heart problems• Bile ducts seen in early biopsies• Progressive bile duct loss/absence• Fibrosis• Abberant Cytokeratin 7 staining in periportal

hepatocytes

Early features

Late Features

4) Bland cholestasis

• Canalicular cholestasis

• No ductular reaction or bile plugging

• Minimal parenchymal changes

• +/- Fibrosis

Pitfalls in children

• Copper-associated protein present in babies up to 3 months (periportal)

• Small amounts of periportal iron present at birth

• Fat not generally seen, metabolic conditions should be considered

• Hepatocyte plates 2 cells thick until 5/6 years

• Erythropoiesis stops approx. 36 weeks gestation

Neonatal Haemochromatosis• Severe form of iron

overload• Starts to accumulate in

utero - can cause fetal death

• Liver failure• Massive necrosis –

collapse• Iron +++• Usually diagnosed on lip

biopsy – iron storage in salivary glands